Structure Stock Soars. Its Obesity Pill Could Challenge Lilly, Novo.
Analysts say that the arrival of cheaper, more convenient obesity pills could mean much broader access for patients, and eventually a larger market.
Source: marketwatch.com
Stay updated with breaking news from Structure Thereapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts say that the arrival of cheaper, more convenient obesity pills could mean much broader access for patients, and eventually a larger market.